Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

RGP to Expand HUGO Digital Staffing Platform Following Successful Pilot: https://mms.businesswire.com/media/20191203005696/en/728410/5/RGP_Logo_Trademarked_red_cmyk.jpg
RGP to Expand HUGO Digital Staffing Platform Following Successful Pilot


RGP (Nasdaq: RGP), a global consulting firm focused on project execution with high quality, experienced and diverse talent, today announced plans to expand digital staffing platform HUGO into the

Biomind Labs to Participate in the PSYCH Symposium at the National Gallery in London: https://mms.businesswire.com/media/20220217005440/en/1363327/5/Biomind_Logo_2022.jpg
Biomind Labs to Participate in the PSYCH Symposium at the National Gallery in London


Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company developing the next generation of pharmaceuticals to treat patients suffering from

NICE Actimize Positioned as Highest-Scoring Vendor Across Technology Excellence Metrics in 2022 Quadrant Knowledge Anti-Money Laundering Report: https://mms.businesswire.com/media/20191203005409/en/615391/5/NICE_inContact.jpg
NICE Actimize Positioned as Highest-Scoring Vendor Across Technology Excellence Metrics in 2022 Quadrant Knowledge Anti-Money Laundering Report


NICE Actimize, a NICE (NASDAQ: NICE) business, has been ranked by global advisory and consulting firm Quadrant Knowledge Solutions as the highest-scoring AML solutions vendor across Technology

CarMax Reports Fourth Quarter and Fiscal Year 2022 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24307/375px-CarMax_Logo.svg.png
CarMax Reports Fourth Quarter and Fiscal Year 2022 Results


CarMax, Inc. (NYSE:KMX) today reported results for the fourth quarter and fiscal year ended February 28, 2022.



Highlights:




  • CarMax’s share of the nationwide age 0-10 year old used vehicle

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
DGAP-News: Linde Announces First Quarter 2022 Earnings and Conference Call Schedule: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23621/TheLindeGroup-Logo.svg.png
DGAP-News: Linde Announces First Quarter 2022 Earnings and Conference Call Schedule
DGAP-News: Linde Announces First Quarter 2022 Earnings and Conference Call Schedule
Annual General Meeting of Julius Baer Group Ltd.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23992/Julius_B%C3%A4r_Logo.svg.png
Annual General Meeting of Julius Baer Group Ltd.
Annual General Meeting of Julius Baer Group Ltd.
Skills Shortage Inspires New Mainframe Plans in Europe: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Skills Shortage Inspires New Mainframe Plans in Europe


Spurred by rising costs and a scarcity of legacy skills, a small but growing number of European enterprises are modernizing their mainframe applications or migrating them to the cloud, according to

DGAP-Adhoc: GRAMMER AG: Earnings development in first quarter of 2022 significantly below prior-year level: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24104/266px-Grammer_AG_Logo.svg.png
DGAP-Adhoc: GRAMMER AG: Earnings development in first quarter of 2022 significantly below prior-year level
DGAP-Adhoc: GRAMMER AG: Earnings development in first quarter of 2022 significantly below prior-year level
Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Nordea's first-quarter results 2022 will be presented on 28 April: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
Nordea's first-quarter results 2022 will be presented on 28 April
Nordea's first-quarter results 2022 will be presented on 28 April
Nordea Bank Abp: Transaction in Own Shares: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24153/330px-Nordea_logo.svg.png
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
DGAP-News: Financial year 2021: Net profit of Mutares Holding rises to record level of EUR 50.7 million, further increase to at least EUR 72.0 million expected for 2022: https://upload.wikimedia.org/wikipedia/commons/thumb/c/c3/MUTARES.png/800px-MUTARES.png
DGAP-News: Financial year 2021: Net profit of Mutares Holding rises to record level of EUR 50.7 million, further increase to at least EUR 72.0 million expected for 2022
DGAP-News: Financial year 2021: Net profit of Mutares Holding rises to record level of EUR 50.7 million, further increase to at least EUR 72.0 million expected for 2022
DGAP-News: Evotec SE fiscal year 2021 results: 'Setting the Pace' on the data-driven R&D Autobahn to Cures: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec SE fiscal year 2021 results: 'Setting the Pace' on the data-driven R&D Autobahn to Cures
DGAP-News: Evotec SE fiscal year 2021 results: 'Setting the Pace' on the data-driven R&D Autobahn to Cures
Asia Pacific’s IT, Business Services Market Up in Q1, But Growth Remains Uneven, ISG Index™ Finds: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Asia Pacific’s IT, Business Services Market Up in Q1, But Growth Remains Uneven, ISG Index™ Finds


Asia Pacific’s IT and business services market grew by 28 percent in the first quarter, but demand slowed dramatically from a record fourth quarter as the region continues to produce uneven

Power Integrations to Release First-Quarter Financial Results on April 28: https://mms.businesswire.com/media/20191127005086/en/440630/5/PI_Logo_Short_black_blue_RGB150.jpg
Power Integrations to Release First-Quarter Financial Results on April 28


Power Integrations (Nasdaq: POWI) will release its first-quarter financial results after market hours on Thursday, April 28, 2022, and will host a conference call that day beginning at 1:30 p.m

COPT Provides Conference Call Details to Discuss 1Q 2022 Results: https://mms.businesswire.com/media/20191107006031/en/58018/5/COPT_2ColorRGB.jpg
COPT Provides Conference Call Details to Discuss 1Q 2022 Results


Corporate Office Properties Trust (NYSE: OFC) (“COPT” or the “Company”) announces the release date and conference call details in which management will discuss first quarter 2022 results

Martin Midstream Partners L.P. Will Host a Conference Call on April 21 to Discuss First Quarter 2022 Earnings
Martin Midstream Partners L.P. Will Host a Conference Call on April 21 to Discuss First Quarter 2022 Earnings


Martin Midstream Partners L.P. (NASDAQ: MMLP) (“MMLP” or the “Partnership”) plans to release its financial results for the first quarter ended March 31, 2022 after the market closes on April 20

NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3


Regulatory News:



NANOBOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for

Inseego Appoints Chuck Becher as SVP and GM of Carrier Solutions: https://mms.businesswire.com/media/20200226005297/en/775865/5/Inseego_logo_high_resolution.jpg
Inseego Appoints Chuck Becher as SVP and GM of Carrier Solutions


Inseego Corp. (Nasdaq: INSG), a leader in 5G and intelligent IoT device-to-cloud solutions, today announced the appointment of Chuck Becher as Senior Vice President and General Manager of Carrier

Orbia Announces Conference Call for Its First Quarter 2022 Earnings Results: https://mms.businesswire.com/media/20200429005967/en/788507/5/Orbia_PrimaryLogo_Blue.jpg
Orbia Announces Conference Call for Its First Quarter 2022 Earnings Results


Orbia Advance Corporation, S.A.B. de C.V. will release its first quarter 2022 earnings results after the market closes on Wednesday, April 27th, 2022.



Management will host a conference call to

Cirrus Logic to Announce Q4 Results May 3
Cirrus Logic to Announce Q4 Results May 3


Cirrus Logic Inc. (Nasdaq: CRUS) today announced that the company will post its fourth quarter and full fiscal year 2022 financial results and business outlook on the investor relations area of its

ISG to Announce First-Quarter Financial Results: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
ISG to Announce First-Quarter Financial Results


Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, said today it will release its first-quarter financial results on Monday, May 9, 2022, at

Poxel Announces PXL770 Awarded FDA Fast Track Designation for X-linked Adrenoleukodystrophy: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces PXL770 Awarded FDA Fast Track Designation for X-linked Adrenoleukodystrophy


POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

Verimatrix Announces Participation in Three NAB Show Sessions, April 24-26 in Las Vegas: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Announces Participation in Three NAB Show Sessions, April 24-26 in Las Vegas


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the following NAB Show sessions taking place